238 related articles for article (PubMed ID: 28153726)
1. K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology.
Sakamoto K; Kamada Y; Sameshima T; Yaguchi M; Niida A; Sasaki S; Miwa M; Ohkubo S; Sakamoto JI; Kamaura M; Cho N; Tani A
Biochem Biophys Res Commun; 2017 Mar; 484(3):605-611. PubMed ID: 28153726
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.
Niida A; Sasaki S; Yonemori K; Sameshima T; Yaguchi M; Asami T; Sakamoto K; Kamaura M
Bioorg Med Chem Lett; 2017 Jun; 27(12):2757-2761. PubMed ID: 28457754
[TBL] [Abstract][Full Text] [Related]
3. Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo.
Sakamoto K; Masutani T; Hirokawa T
Sci Rep; 2020 Dec; 10(1):21671. PubMed ID: 33303890
[TBL] [Abstract][Full Text] [Related]
4. Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.
Sogabe S; Kamada Y; Miwa M; Niida A; Sameshima T; Kamaura M; Yonemori K; Sasaki S; Sakamoto JI; Sakamoto K
ACS Med Chem Lett; 2017 Jul; 8(7):732-736. PubMed ID: 28740607
[TBL] [Abstract][Full Text] [Related]
5. K-Ras
Feng H; Zhang Y; Bos PH; Chambers JM; Dupont MM; Stockwell BR
Biochemistry; 2019 May; 58(21):2542-2554. PubMed ID: 31042025
[TBL] [Abstract][Full Text] [Related]
6. Computational investigation to identify potent inhibitors of the GTPase-Kirsten RAt sarcoma virus (K-Ras) mutants G12C and G12D.
Kumar SU; Priya Doss CG
Comput Biol Med; 2021 Dec; 139():104946. PubMed ID: 34715554
[TBL] [Abstract][Full Text] [Related]
7. Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis.
Sakamoto K; Sogabe S; Kamada Y; Matsumoto SI; Kadotani A; Sakamoto JI; Tani A
Biochem Biophys Res Commun; 2017 Jan; 482(2):195-201. PubMed ID: 27836545
[TBL] [Abstract][Full Text] [Related]
8. The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors.
Sakamoto K; Lin B; Nunomura K; Izawa T; Nakagawa S
Sci Rep; 2022 May; 12(1):8121. PubMed ID: 35581303
[TBL] [Abstract][Full Text] [Related]
9.
Pálfy G; Vida I; Perczel A
Biomol NMR Assign; 2020 Apr; 14(1):1-7. PubMed ID: 31468366
[TBL] [Abstract][Full Text] [Related]
10. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
[TBL] [Abstract][Full Text] [Related]
11. Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS
Wang X; Allen S; Blake JF; Bowcut V; Briere DM; Calinisan A; Dahlke JR; Fell JB; Fischer JP; Gunn RJ; Hallin J; Laguer J; Lawson JD; Medwid J; Newhouse B; Nguyen P; O'Leary JM; Olson P; Pajk S; Rahbaek L; Rodriguez M; Smith CR; Tang TP; Thomas NC; Vanderpool D; Vigers GP; Christensen JG; Marx MA
J Med Chem; 2022 Feb; 65(4):3123-3133. PubMed ID: 34889605
[TBL] [Abstract][Full Text] [Related]
12. GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf.
Zhang Z; Gao R; Hu Q; Peacock H; Peacock DM; Dai S; Shokat KM; Suga H
ACS Cent Sci; 2020 Oct; 6(10):1753-1761. PubMed ID: 33145412
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic G12D mutation alters local conformations and dynamics of K-Ras.
Vatansever S; Erman B; Gümüş ZH
Sci Rep; 2019 Aug; 9(1):11730. PubMed ID: 31409810
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Inhibitors Targeting GTPase-Kirsten RAt Sarcoma Virus (K-Ras) Driven Cancers via E-Pharmacophore-Based Virtual Screening and Drug Repurposing Approach.
Kumar S U; Varghese RP; Preethi VA; Doss CGP; Zayed H
Front Biosci (Landmark Ed); 2023 Nov; 28(11):288. PubMed ID: 38062837
[TBL] [Abstract][Full Text] [Related]
15. Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration.
Sakamoto K; Adachi Y; Komoike Y; Kamada Y; Koyama R; Fukuda Y; Kadotani A; Asami T; Sakamoto JI
Biochem Biophys Res Commun; 2017 Jan; 483(1):183-190. PubMed ID: 28039053
[TBL] [Abstract][Full Text] [Related]
16. Nanoformulation of the K-Ras(G12D)-inhibitory peptide KS-58 suppresses colorectal and pancreatic cancer-derived tumors.
Sakamoto K; Qi Y; Miyako E
Sci Rep; 2023 Jan; 13(1):518. PubMed ID: 36627374
[TBL] [Abstract][Full Text] [Related]
17. Identification of cytidine-5-triphosphate synthase1-selective inhibitory peptide from random peptide library displayed on T7 phage.
Sakamoto K; Ishibashi Y; Adachi R; Matsumoto SI; Oki H; Kamada Y; Sogabe S; Zama Y; Sakamoto JI; Tani A
Peptides; 2017 Aug; 94():56-63. PubMed ID: 28676225
[TBL] [Abstract][Full Text] [Related]
18. Computational Design of Myristoylated Cell-Penetrating Peptides Targeting Oncogenic K-Ras.G12D at the Effector-Binding Membrane Interface.
Li Z; Buck M
J Chem Inf Model; 2020 Jan; 60(1):306-315. PubMed ID: 31855604
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Thieno[2,3-d]pyrimidine-based KRAS G12D inhibitors as potential anticancer agents via combinatorial virtual screening.
Li L; Liu J; Yang Z; Zhao H; Deng B; Ren Y; Mai R; Huang J; Chen J
Eur J Med Chem; 2022 Apr; 233():114243. PubMed ID: 35276423
[TBL] [Abstract][Full Text] [Related]
20. Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods.
Kulkarni AM; Kumar V; Parate S; Lee G; Yoon S; Lee KW
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
